- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A UK senior employee ‘liked’ a global corporate LinkedIn post linking to product milestone news. The Panel said this proactively disseminated promotional…
Anonymous HCP alleged Roche’s Ocrevus promotional webpage implied only 1 hour monitoring and omitted “dedicated line” administration. Panel found the timeline clearly…
A third-party newsletter ran a “Sponsored” block linking to AZ’s Forxiga promotional microsite, but the email didn’t name AstraZeneca, didn’t make the…
PMCPA case AUTH/3870/1/24 against AstraZeneca concerned allegations about clinical trial material. The matter was found outwith the scope of the ABPI Code:…
Complaint alleged Proveca’s Sialanar pages were promoted via Google/SEO and inaccessible to the public. Panel found search results reflected Google indexing, HCP…
A health professional complained that a patient accessed the Eylea SmPC via Bayer’s patient website. The Panel found the site appropriately separated…
PMCPA ruled AstraZeneca breached Clause 5.5 after sponsorship of a severe asthma article was only declared in an acknowledgements section near the…
Complaint alleged a third‑party promotional email for Xarelto omitted contraindications/special warnings (renal impairment) and breached a prior undertaking. PMCPA Panel ruled no…
Complaint alleged Roche sponsorship wasn’t declared prominently from the outset on a partnership website and breached a prior undertaking. PMCPA Panel found…
A BBC radio programme about a Roche-sponsored eye health campaign featured partner interviews without declaring Roche’s sponsorship during the audio. PMCPA ruled…
A UK health professional complained that a BMJ-hosted DuoResp Spiromax ad implied broader licensed use than permitted and relied on footnotes. The…
Allergan challenged Xeomin promotional claims in a BMJ ad, leavepiece and conference stand panels. The Panel ruled some claims misleading about complexing…
A competitor challenged Guerbet’s exhibition claim that Dotarem had the “highest Stability”. Although the claim was considered true, the context could imply…
A GP challenged Pfizer’s Toviaz ads comparing fesoterodine 8mg with tolterodine ER 4mg. The PMCPA ruled the comparative claims misleading and unsubstantiated,…
A dermatologist alleged a Ranbaxy letter implied Co-Cyprindiol contained isotretinoin and erythromycin. The Panel found no breach of Clause 7.2, but said…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.